EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613PRNewsWire • 11/07/23
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in BrazilPRNewsWire • 09/06/23
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger AgreementPRNewsWire • 12/02/21
ImmunoCellular Therapeutics Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) MarketPRNewsWire • 06/28/21